Gilead Sciences, Inc. (GILD)
166.89
-0.68
(-0.41%)
USD |
NASDAQ |
Nov 06, 16:00
166.00
-0.89
(-0.53%)
After-Hours: 20:00
Gilead Sciences Price to Book Value : 15.89 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 15.89 |
| November 05, 2026 | 15.95 |
| November 04, 2026 | 16.61 |
| November 03, 2026 | 15.94 |
| November 02, 2026 | 16.21 |
| October 30, 2026 | 16.25 |
| October 29, 2026 | 15.76 |
| October 28, 2026 | 15.15 |
| October 27, 2026 | 15.14 |
| October 26, 2026 | 15.10 |
| October 23, 2026 | 14.85 |
| October 22, 2026 | 14.96 |
| October 21, 2026 | 14.62 |
| October 20, 2026 | 14.90 |
| October 19, 2026 | 14.57 |
| October 16, 2026 | 14.87 |
| October 15, 2026 | 14.98 |
| October 14, 2026 | 14.61 |
| October 13, 2026 | 14.08 |
| October 12, 2026 | 14.32 |
| October 09, 2026 | 14.39 |
| October 08, 2026 | 14.00 |
| October 07, 2026 | 13.98 |
| October 06, 2026 | 13.73 |
| October 05, 2026 | 13.77 |
| Date | Value |
|---|---|
| October 02, 2026 | 13.78 |
| October 01, 2026 | 14.04 |
| September 30, 2026 | 14.19 |
| September 29, 2026 | 15.87 |
| September 28, 2026 | 15.97 |
| September 25, 2026 | 15.83 |
| September 24, 2026 | 15.70 |
| September 23, 2026 | 15.88 |
| September 22, 2026 | 16.02 |
| September 21, 2026 | 15.80 |
| September 18, 2026 | 15.75 |
| September 17, 2026 | 15.83 |
| September 16, 2026 | 15.49 |
| September 15, 2026 | 15.35 |
| September 14, 2026 | 15.36 |
| September 11, 2026 | 15.08 |
| September 10, 2026 | 15.19 |
| September 09, 2026 | 15.28 |
| September 08, 2026 | 15.38 |
| September 04, 2026 | 15.84 |
| September 03, 2026 | 15.86 |
| September 02, 2026 | 15.70 |
| September 01, 2026 | 15.73 |
| August 31, 2026 | 15.35 |
| August 28, 2026 | 15.28 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.792 |
| AbbVie, Inc. | -- |
| Biogen, Inc. | 1.940 |
| Vertex Pharmaceuticals, Inc. | 6.634 |
| Amgen, Inc. | 17.35 |
Price to Book Value Related Metrics
| PS Ratio | 6.717 |
| Price to Free Cash Flow | 15.14 |
| Price | 166.89 |
| Earnings Yield | -1.89% |
| Market Cap | 207.11B |
| Operating PE Ratio | 17.50 |
| Normalized PE Ratio | 36.51 |